IPP Bureau
Hester Biosciences to acquire 50 % stake in Thrishool Exim, Tanzania
By IPP Bureau - November 11, 2021
The consideration for the acquisition is US $ 2.25 million
Sudeep Pharma ventures into nutrition
By IPP Bureau - November 11, 2021
Sudeep Nutrition will be a one-stop solution for food, beverage, nutraceuticals and nutritional product manufacturers
Clinical study shows ViroStop spray prevents Covid-19
By IPP Bureau - November 11, 2021
Evidence also shows better immune response to virus among users of spray
LifeCell Diagnostics expands newborn screening portfolio
By IPP Bureau - November 11, 2021
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
.png "Medtronic first to launch cryoballoon catheter in India")
Medtronic first to launch cryoballoon catheter in India
By IPP Bureau - November 10, 2021
Cryoballoon catheter ablation, a minimally invasive procedure, is one of the therapeutic modalities to manage Atrial fibrillation
Moderna seeks approval from EMA for its Covid-19 vaccine for children between 6-11 years
By IPP Bureau - November 10, 2021
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
US govt places additional order of 1.4 million courses of molnupiravir
By IPP Bureau - November 10, 2021
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
Lupin partners with Shaan to raise awareness on mental health
By IPP Bureau - November 10, 2021
Shaan’s hit song `Tanha Dil Tanha Safar relaunched
Pulmatrix resolves dispute with Cipla
By IPP Bureau - November 10, 2021
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
India Pharmaceutical Market grows 5% in October 2021
By IPP Bureau - November 10, 2021
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
AstraZeneca Pharma India PAT at Rs 11.94 cr. in Q2FY22
By IPP Bureau - November 10, 2021
The Board of Directors of AstraZeneca Pharma India have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
Zydus Cadila receives approval for glycopyrrolate injection
By IPP Bureau - November 10, 2021
Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated
Marksons Pharma PAT slips to Rs 46.28 in Q2FY22
By IPP Bureau - November 10, 2021
Marksans Pharma has reported consolidated financial results for the period ended September 30, 2021
Intuitive India familiarises surgeons on Robotic-Assisted Surgery
By IPP Bureau - November 10, 2021
The workshop had been organized by the department of surgery at Jawaharlal Nehru Medical College (JNMC), Aligarh Muslim University (AMU), along with the Association of Surgeons of Aligarh (ASA)
Strides Pharma Science incurs Rs 162.55 cr. loss in Q2FY22
By IPP Bureau - November 10, 2021
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
